This study aims to improve the early detection and management of preeclampsia (a serious blood pressure condition) that develops after childbirth. You might be able to join if you are pregnant, at least 18 years old, delivering at Dhulikhel Hospital, and have certain risk factors for preeclampsia. Before delivery, your risk will be assessed using a blood test (sFlt-1/PlGF ratio). If you are at high risk, you will be randomly assigned to either receive standard care or a special care bundle. This bundle includes remote blood pressure monitoring, education, and the medication nifedipine ER for mild blood pressure changes. The main goal is to see if these study procedures are practical and well-received. The study is currently recruiting 60 participants, but its overall status is unclear.

Study design

This is a pilot randomized controlled trial involving 60 pregnant patients. Participants at high risk for preeclampsia will be randomly assigned to receive either an intervention bundle or routine postpartum care.

What's involved

You will undergo a preeclampsia risk assessment blood test before delivery. If at high risk, you may receive remote blood pressure monitoring, education, and medication (nifedipine ER) for outpatient management.

Compensation

Not stated in the trial record.

Follow-up

The study's feasibility, which is the primary endpoint, will be measured at 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.